ebook img

The Ethics of Synthetic Biology and Emerging Technologies PDF

192 Pages·2010·3.96 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview The Ethics of Synthetic Biology and Emerging Technologies

836a 837a 838a 839a 840a 841a 842a 843a 0039 0041 0040 0042 0043 878 879 880 881 882 883 884 885 0076 0077 0078 0079 0081 918 919 920 921 922 923 924 925 0112 0113 0114 0115 0117 962 963 964 965 966 967 968 969 0145 0146 0147 0150 1002 1003 1004 1005 1006 1007 1008 1009 0172 0173 0175 0 177 1042 1043 1044 1045 1046 1047 1048 1049 0203 0204 0205 0206 0207 0208 1082 1083 1084 1085 1086 1087 1088 1089 0239 0240 0241 0242 21 22 23 24 25 26 27 28 0272 0273 62 63 64 65 66 67 68 69 0004 0005 0008 0009 NEW DIRECTIONS 102 103 104 105 106 107 108 109 0338 0339 0340 0341 e Ethics of Synthetic Biology 142 143 144 145 146 147 148 149 0377 0380 0386 and Emerging Technologies 182 183 184 185 186 187 188 189 0407 0410 0411 0412 222 223 224 225 226 227 228 229 0441 0444 0445 0479 0480 0484 0485 307 308 309 310 311 312 313 314 0523 0524 0528 0529 347 348 349 350 351 352 353 354 0555 0556 0557 0559 0560 387 388 389 390 391 392 393 394 0583 0584 0585 427 428 429 430 431 432 433 434 0604 0606 0607 0608 0609 0610 467 468 469 470 471 472 473 474 cobalt 0640 0641 0642 0643 0645 507 508 509 510 511 512 513 514 0682 0683 0685 0686 0687 0688 547 0734548 007573043579637 5057038 050750731749410 552TyCpCe0T 5I7IT5 RC43M2 554 Presidential Commission 587 588 589 590 591 592 593 594 for the Study of Bioethical Issues 0770 0771 0773 0775 Presidential Commission for the Study of Bioethical Issues 627 628 629 630 631 632 633 634 1425 New York Avenue, Suite C-100 0804 0805 0806 Washington, D.C.  20005 December 2010 667 668 669 670 671 672 673 674 (202) 233-3960 0841 www.bioethics.gov 707 708 709 710 711 712 713 714 0870 0872 0875 747 748 749 750 751 752 753 754 0898 0899 787 788 789 790 791 792 793 794 NEW DIRECTIONS e Ethics of Synthetic Biology and Emerging Technologies Presidential Commission for the Study of Bioethical Issues December 2010 004309 0769 0238 0202 0408 0378 0071 0684 0605 052576 04432 0409 0378 0174 0 00010 007345 00076 0 07742 0644 0558 048312 0382431 0007 0176 01498 0080 00032 0077 001008 0 0649678 0561 0530 044867 0385 0116 00832 00446 NEW DIRECTIONS e Ethics of Synthetic Biology and Emerging Technologies Presidential Commission for the Study of Bioethical Issues Washington, D.C. December 2010 www.bioethics.gov NEW DIRECTIONS Te Ethics of Synthetic Biology and Emerging Technologies ABOuT ThE PRESIDENTIAl COmmISSION fOR ThE STuDy Of BIOEThICAl ISSuES Te Presidential Commission for the Study of Bioethical Issues (PCSBI) is an advisory panel of the nation’s leaders in medicine, science, ethics, religion, law, and engineering. PCSBI advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. Te Commission seeks to identify and promote policies and practices that ensure scientifc research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. for more information about PCSBI, please see www.bioethics.gov. On the front cover: Portion of the genome map of M. mycoides JCVI-syn1.0. From Gibson, D.G., et al. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329(5987):52-56. ii CONTENTS letter of Transmittal to the President ...........................................................................v letter from the President to the Commission ...........................................................vi members of the Commission ........................................................................................vii Commission Staf ............................................................................................................viii Acknowledgements ............................................................................................................ix Executive Summary ...........................................................................................................1 ChAPTER 1 Introduction ..........................................................................................19 ChAPTER 2 Science of Synthetic Biology .............................................................35 ChAPTER 3 Applications, Benefts, and Risks ....................................................55 ChAPTER 4 Oversight................................................................................................79 ChAPTER 5 Analysis and Recommendations ................................................... 111 Public Benefcence .............................................................................113 Responsible Stewardship .................................................................123 Intellectual freedom and Responsibility ....................................141 Democratic Deliberation ................................................................. 151 Justice and fairness ...........................................................................161 Appendix: Guest Speakers ............................................................................................175 iii NEW DIRECTIONS Te Ethics of Synthetic Biology and Emerging Technologies iv PRESIDENTIAL COMMISSION FOR THE STUDY OF BIOETHICAL ISSUES President Barack Obama The White House 1600 Pennsylvania Avenue, NW Washington, DC 20500 Dear Mr. President: We are pleased to present to you this report, New Directions: The Ethics of Synthetic Biology and Emerging Technologies. In response to your request of May 20, 2010, this first report of the Presidential Commission for the Study of Bioethical Issues (PCSBI) examines the implications of the emerging science of synthetic biology, including the announcement in May of the successful creation of a self-replicating bacterial cell with a completely synthetically-replicated genome. It offers recommendations to ensure that America reaps the benefits of this developing field within appropriate ethical boundaries. PCSBI approached this task through inclusive and deliberative engagement with ethicists, scientists, engineers, and individuals in faith, business, and non-profit communities. We held three public meetings, both in and outside of Washington, D.C., created an open forum for dialogue, and heard many diverse voices. The Commission found that synthetic biology offers extraordinary promise to create new products for clean energy, pollution control, and medicine, to revolutionize chemical production and manufacturing, and to create new economic opportunities. With this promise comes a duty to attend carefully to potential risks, be responsible stewards, and consider thoughtfully the implications for humans, other species, nature, and the environment. PCSBI concluded that synthetic biology is capable of significant but limited achievements posing limited risks. Future developments may raise further objections, but the Commission found no reason to endorse additional federal regulations or a moratorium on work in this field at this time. Instead, the Commission urges monitoring and dialogue between the private and public sectors to achieve open communication and cooperation. The Commission recommends that the government, through a coordinated process or body within the Executive Office of the President, lead an ongoing review of developments, risks, opportunities, and oversight as this field grows. This review should be in consultation with relevant scientific, academic, international, and public communities, and whenever possible its results should be made public. We also recommend that reasonable risk assessment should precede any field release of synthetic organisms. We suggest support for public engagement, education, and dialogue to ensure public trust and avoid unnecessary limitations on science and social progress. You gave the Commission a rare and exceptional opportunity to be proactive and forward looking in this first study. The Commission is grateful for the opportunity to serve you and the nation in this way. We would be happy to brief you if you have any questions about our recommendations. Sincerely, Amy Gutmann, Ph.D. James Wagner, Ph.D. Chair Vice-Chair 1425 NEW YORK AVENUE, NW, SUITE C-100 , WASHINGTON, DC 20005 PHONE 202 -233 -3960 FAX 202 -233 -3990 WWW.BIOETHICS .GOV v NEW DIRECTIONS Te Ethics of Synthetic Biology and Emerging Technologies vi PRESIDENTIAl COmmISSION fOR ThE STuDy Of BIOEThICAl ISSuES Amy GuTmANN, Ph.D., ChAIR President and Christopher h. Browne Distinguished Professor of Political Science, university of Pennsylvania JAmES W. WAGNER, Ph.D., VICE ChAIR President, Emory university yOlANDA AlI ChRISTINE GR ADy, R.N., Ph.D. michael J. fox foundation Acting Chief of the Department of founder’s Council; Bioethics, National Institutes of health Emory Neurosciences Clinical Center Community Advisory Board STEPhEN l. hAuSER, m.D. Robert A. fishman Distinguished ANITA l. AllEN, J.D., Ph.D. Professor and Chair of the Department Deputy Dean for Academic Afairs; of Neurology, university of California, henry R. Silverman Professor of law, San francisco Professor of Philosophy, university of Pennsylvania law School R AJu S. KuChERlAPATI, Ph.D. Paul C. Cabot Professor, Department JOhN D. ARR AS, Ph.D. of Genetics, harvard medical School; Porterfeld Professor of Biomedical Professor, Department of medicine, Ethics, Professor of Philosophy, Brigham and Women’s hospital university of Virginia BARBAR A f. ATKINSON, m.D. NElSON l. mIChAEl, m.D., Ph.D. Executive Vice Chancellor, Colonel, medical Corps, u.S. Army; university of Kansas medical Center; Director, Division of Retrovirology; Executive Dean, university of Walter Reed Army Institute of Research; Kansas School of medicine u.S. military hIV Research Program NITA A. fAR AhANy, J.D., Ph.D. DANIEl P. SulmASy, m.D. Associate Professor of law, Kilbride-Clinton Professor of medicine Associate Professor of Philosophy, and Ethics, Department of medicine Vanderbilt university and Divinity School; Associate Director, maclean Center for Clinical medical AlEXANDER G. GARZA, m.D., m.P.h. Ethics, university of Chicago Assistant Secretary, Ofce of health Afairs; Chief medical Ofcer, Department of homeland Security vii NEW DIRECTIONS Te Ethics of Synthetic Biology and Emerging Technologies PRESIDENTIAl COmmISSION fOR ThE STuDy Of BIOEThICAl ISSuES STAff AND CONSulTANTS Executive Director Valerie h. Bonham, J.D. Research Staf Debbie forrest, m.P.P. Chris havasy, Sc.B. holly fernandez lynch, J.D., m. Bioethics David G. miller, Ph.D. Anne Pierson, J.D. Candidate, 2011 Jason l. Schwartz, A.m., m. Bioethics Kayte Spector-Bagdady, J.D., m. Bioethics Consultants Burness Communications Alison Davis, Ph.D. Kathi E. hanna, m.S., Ph.D. Administrative Staf Judith E. Crawford Esther yoo, B.A. viii

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.